Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
YI01 - Young Investigators Session
- 08:00 - 11:30
- 9/23/2018
- Location: Room 106
- Type: Young Investigator Session
- Track:
-
+
YI01.04 - Planning a Career in Lung Cancer - Bench to Beside
08:30 - 08:40 | Presenter: Pasi A Jänne
- Abstract
No abstract available for this presentation
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.07 - Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer
11:35 - 11:45 | Presenter: Junji Tsurutani | Author(s): Haeseong Park, Toshihiko Doi, Shanu Modi, Shunji Takahashi, Kazuhiko Nakagawa, Ian E. Krop, Saiama N. Waqar, Kiyotaka Yoh, Bob T. Li, Shinichiro Taira, Takahiro Jikoh, Jasmeet Singh, Masahiro Sugihara, Pasi A Jänne
- Abstract
Loading...
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.01 - Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy
13:30 - 13:40 | Presenter: Matthew D. Hellmann | Author(s): Pasi A Jänne, Mateusz Opyrchal, Navid Hafez, Luis E Raez, Dmitry Gabrilovich, Fang Wang, Peter Ordentlich, Susan Brouwer, Serap Sankoh, Emmett Schmidt, Michael L Meyers, Suresh S. Ramalingam
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-41 - A Phase 2 Study of DS-8201a in HER2-Overexpressing or -Mutated Advanced Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Pasi A Jänne | Author(s): Bob T. Li, Haruyasu Murakami, Ryota Shiga, Caleb C. Lee, Kongming Wang, David Planchard
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-44 - Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
16:45 - 18:00 | Presenter: Joel W. Neal | Author(s): Robert C. Doebele, Gregory J Riely, Alexander Spira, Leora Horn, Zofia Piotrowska, Daniel B Costa, Steven Zhang, Dean Bottino, Jian Zhu, David Kerstein, Shuanglian Li, Pasi A Jänne
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-43 - Phase 1 Study of the Anti-HER3 Antibody Drug Conjugate U3-1402 in Metastatic or Unresectable EGFR-Mutant NSCLC
16:45 - 18:00 | Presenter: Pasi A Jänne | Author(s): Helena Yu, Melissa L. Johnson, Conor E. Steuer, Michele Vigliotti, Nicole Shipitofsky, Ferdinand Morales Guevara, Shuquan Chen, Channing Yu
- Abstract
Loading... -
+
P2.13-45 - SHERLOC: A Phase 2 Study of Seribantumab in Combination with Docetaxel in Patients with Heregulin Positive, Advanced NSCLC
16:45 - 18:00 | Presenter: Lecia Sequist | Author(s): Pasi A Jänne, Frances A Shepherd, Rudolf M Huber, Jhanelle Elaine Gray, Enriqueta Felip, Maurice Pérol, Fred R. Hirsch, Daniel S.W. Tan, Kim Caliri, Sara Ghassemifar, Ben Wang, Walid Kamoun, Sergio Santillana, Vasileios Askoxylakis, J Marc Pipas
- Abstract
Loading...
-
+
MS23 - What's New in Targeted Therapy?
- 10:30 - 12:00
- 9/26/2018
- Location: Room 106
- Type: Mini Symposium
- Track: Targeted Therapy
-
+
MS23.01 - Novel Combinations of Targeted Therapies
10:30 - 10:45 | Presenter: Pasi A Jänne
- Abstract
No abstract available for this presentation